熱門Ptt文章

[爆卦]aml分期是什麼？優點缺點精華區懶人包

雖然這篇aml分期鄉民發文沒有被收入到精華區：在aml分期這個話題中，我們另外找到其它相關的精選爆讚文章

「aml分期」的推薦目錄
  • FindDocTV@FindDoc.com

    aml分期 在 [email protected] Youtube 的最讚貼文

    2020-02-19 15:15:57

    慢性骨髓性白血病不是絕症？－ 陳敏航血液及血液腫瘤科專科醫生＠FindDoc.com

    FindDoc Facebook : https://www.facebook.com/FindDoc
    FindDoc WeChat : 快徳健康香港 FindDoc
    FindDoc Instagram：@finddochk

    （一）慢性骨髓性白血病有什麼治療方法？ 00:06

    （二）慢性骨髓性白血病是不是“絕症”？ 00:31

    （三）TKI能使慢性骨髓性白血病痊愈嗎？ 01:24

    （四）病人是否要一直服藥來控制病情，不能停藥？ 02:10

    （五） 醫生對慢性骨髓性白血病有什麼建議？ 03:12

    (本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)

    參考資料：
    1. Falchi, L., Kantarjian, H. M., Wang, X., Verma, D., Quintás-Cardama, A., O'Brien, S., … Cortes, J. E. (2013). Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors. American journal of hematology, 88(12), 1024–1029. doi:10.1002/ajh.23560
    2. Cortes JE, Saglio G, Kantarjian HM, et al. Final 5-year study results of DASISION: the dasatinib versus imatainib study in treatment-nviae chronic myeloid leukemia patients trial. J Clin Oncol 2016;34:2333-2340
    3. Hochhaus A, Saglio G, Hughes TP, et al. Long-term benefits and risks of Goldberg, S. L., Savona, M., & Mauro, M. J. (2018). Considerations for Successful Treatment-free Remission in Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia, 18(2), 98-105. doi:10.1016/j.clml.2017.11.006 frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5 year update of the randomized ENESTnd trial. Leukemia 2016;30:1044-1054
    4. Stem Cell Transplant for Chronic Myeloid Leukemia. (n.d.). Retrieved from https://www.cancer.org/cancer/chronic-myeloid-leukemia/treating/bone-marrow-stem-cell.html
    5. Talpaz, M., Mercer, J., & Hehlmann, R. (2015). The interferon-alpha revival in CML. Annals of Hematology, 94(Supplement 2), 195-207.
    6. Bower, H., Björkholm, M., Dickman, P. W., Höglund, M., Lambert, P. C., & Andersson, T. M. (2016). Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. Journal of Clinical Oncology, 34(24), 2851-2857. doi:10.1200/jco.2015.66.2866
    7. Timothy P. Hughes, Carla Boquimpani, Naoto Takahashi, et al.(2018). ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib, 18, S222. doi:https://doi.org/10.1016/j.clml.2018.07.092
    8. Francis J. Giles, Tamas Masszi, María Teresa Gómez Casares, et al. (2019). Treatment-free remission (TFR) following frontline (1L) nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): 192-week data from the ENESTfreedom study. Journal of Clinical Oncology 2019 37:15_suppl, 7013-7013

    查詢醫生資訊： https://www.finddoc.com/

    post-title

你可能也想看看

搜尋相關網站